← Open Payments lookup

CAMERON CAMPBELL: Open Payments

NPI 1497149348 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$341 in 16 payments from 9 companies in 2025. Trend: 2023 $409 · 2024 $377 · 2025 $341

Food & beverage: $341
CompanyPaymentsAmount
PFIZER INC.6$122
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
ABBVIE INC.2$41
GENZYME CORPORATION1$30
Vanda Pharmaceuticals Inc.1$29
GlaxoSmithKline, LLC.1$29
Gilead Sciences, Inc.1$19
Boehringer Ingelheim Pharmaceuticals, Inc.1$16
TMS NeuroHealth Centers Inc.1$16

Products named: NURTEC ODT, CAPLYTA, SARCLISA, HETLIOZ, TRELEGY ELLIPTA, QULIPTA, UBRELVY, ELIQUIS.

Industry payments across MD — which companies pay providers there.